CY1119486T1 - Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο - Google Patents

Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο

Info

Publication number
CY1119486T1
CY1119486T1 CY20171101019T CY171101019T CY1119486T1 CY 1119486 T1 CY1119486 T1 CY 1119486T1 CY 20171101019 T CY20171101019 T CY 20171101019T CY 171101019 T CY171101019 T CY 171101019T CY 1119486 T1 CY1119486 T1 CY 1119486T1
Authority
CY
Cyprus
Prior art keywords
polymer
amin
american
amine
condition
Prior art date
Application number
CY20171101019T
Other languages
Greek (el)
English (en)
Inventor
Steven K. Burke
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of CY1119486T1 publication Critical patent/CY1119486T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CY20171101019T 2001-04-18 2017-09-27 Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο CY1119486T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28444501P 2001-04-18 2001-04-18
US30556401P 2001-07-13 2001-07-13
EP02726733A EP1392331B1 (en) 2001-04-18 2002-04-10 Use of colesevelam or sevelamer hydrogen chloride for lowering serum glucose

Publications (1)

Publication Number Publication Date
CY1119486T1 true CY1119486T1 (el) 2018-03-07

Family

ID=26962623

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101019T CY1119486T1 (el) 2001-04-18 2017-09-27 Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο

Country Status (17)

Country Link
US (2) US7229613B2 (https=)
EP (1) EP1392331B1 (https=)
JP (2) JP4499363B2 (https=)
KR (1) KR20040018358A (https=)
CN (1) CN1511039A (https=)
AT (1) ATE390927T1 (https=)
AU (1) AU2002257145B2 (https=)
BR (1) BRPI0209134B8 (https=)
CA (1) CA2444046C (https=)
CY (1) CY1119486T1 (https=)
DE (1) DE60225908T2 (https=)
DK (2) DK1392331T3 (https=)
ES (2) ES2637020T3 (https=)
MX (1) MXPA03009568A (https=)
NZ (1) NZ528831A (https=)
PT (1) PT1923064T (https=)
WO (1) WO2002085377A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
AU2002257145B2 (en) * 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
CA2560927C (en) * 2004-03-26 2013-05-14 Mitsubishi Pharma Corporation Insulin resistance-improving agent
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
CA2749074A1 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US8710154B2 (en) * 2008-09-15 2014-04-29 Shasun Pharmaceuticals Limited Non-aqueous solution process for the preparation of cross-linked polymers
EP2389168A2 (en) * 2009-01-22 2011-11-30 USV Limited Pharmaceutical compositions comprising phosphate-binding polymer
WO2014122586A1 (en) 2013-02-08 2014-08-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
HK1220607A1 (zh) * 2013-03-15 2017-05-12 Genzyme Corporation 晚期糖化终产物(age)前体的螯合剂
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3564292B1 (en) 2016-12-28 2021-06-16 FUJIFILM Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
CN111225674A (zh) 2017-10-16 2020-06-02 富士胶片株式会社 高磷血症治疗剂
WO2023023938A1 (en) * 2021-08-24 2023-03-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia
EP4164659B1 (en) 2021-08-24 2024-03-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528847A (en) * 1983-10-04 1985-07-16 D. Halmi And Associates, Inc. Flow metering device with recessed pressure taps
JPS6090243A (ja) 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
US4528347A (en) 1983-11-10 1985-07-09 501 Nitto Boseki, Co. Ltd Process for producing polymers of monoallylamine
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
JP3507523B2 (ja) 1993-05-12 2004-03-15 積水化学工業株式会社 糖質吸収抑制剤
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5900475A (en) 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
JP4156684B2 (ja) * 1996-03-05 2008-09-24 三菱化学株式会社 高リン血症予防および／または治療剤
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
FR2766195A1 (fr) 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
PT1140185E (pt) * 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com agentes sequestrantes de acido biliar para indicacoes cardiovasculares
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
AU2002257145B2 (en) * 2001-04-18 2005-06-02 Genzyme Corporation Method for lowering serum glucose
WO2002100397A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND AN ANTILIPEMIC AGENT

Also Published As

Publication number Publication date
CA2444046A1 (en) 2002-10-31
US20020187121A1 (en) 2002-12-12
ATE390927T1 (de) 2008-04-15
DE60225908T2 (de) 2009-05-14
BR0209134A (pt) 2004-06-15
JP2010090172A (ja) 2010-04-22
DK1392331T3 (da) 2008-06-23
ES2304437T3 (es) 2008-10-16
EP1392331A1 (en) 2004-03-03
JP2004535384A (ja) 2004-11-25
KR20040018358A (ko) 2004-03-03
US7229613B2 (en) 2007-06-12
CN1511039A (zh) 2004-07-07
NZ528831A (en) 2005-07-29
CA2444046C (en) 2011-06-07
JP4499363B2 (ja) 2010-07-07
EP1392331B1 (en) 2008-04-02
PT1923064T (pt) 2017-08-23
ES2637020T3 (es) 2017-10-10
BRPI0209134B1 (pt) 2019-08-27
WO2002085377A1 (en) 2002-10-31
AU2002257145B2 (en) 2005-06-02
DE60225908D1 (de) 2008-05-15
MXPA03009568A (es) 2004-02-12
DK1923064T3 (en) 2017-10-02
US20070286841A1 (en) 2007-12-13
WO2002085377A8 (en) 2002-11-28
BRPI0209134B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
CY1119486T1 (el) Χρηση πολυμερους αμινης για μειωση της γλυκοζης στον ορο
ATE380553T1 (de) Aminpolymere zur behandlung von gicht und zur senkung des harnsäuregehaltes
IL133434A (en) Use of polyamine polymers in the preparation of medicaments for removing bile salts and for treating hypercholesterolemia
ATE287911T1 (de) Verwendung von poly(diallylamin) polymeren
DE69935799D1 (de) Therapeutische zusammenstellungen
EA200401365A1 (ru) Способы лечения илеуса
ATE372355T1 (de) Dl-lactid-e-caprolacton copolymere
IL159166A0 (en) Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
EA200500782A1 (ru) Лечение геморрагического шока
ATE328865T1 (de) Okklusionszusammensetzung umfassend ein poly(2- cyanoacrylat)-monomer
MXPA04004026A (es) Conjugados polimericos de inhibidores de la proteina quinasa c.
EP1262530A4 (en) ADHESIVE COMPOSITION
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
MXPA04000317A (es) Un copolimero de bloque amfifilico cargado positivamente como un vehiculo de medicamento y complejo del mismo con un medicamento cargado negativamente.
SE0102147D0 (sv) New methods
NZ590128A (en) Prodrugs of HIV protease inhibitors
EP1923064A3 (en) Use of amine polymer for lowering serum glucose
BRPI0413682A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
JP2002500183A5 (https=)
MY122400A (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
BRPI0507853A (pt) processo para o tratamento de material de fibra e nova composição
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
NO20034453L (no) Anvendelse av CD25-bindende molekyler i steroid-resistente pasienter